Enquiries to the manufacturer should be addressed to:Dr David Dunham
Regulatory Affairs Manager – UK & Ireland
Medtronic Limited
Suite One
Sherbourne House
Croxley Green Business Park
Watford WD18 8WW
Tel: 01923 212213
Fax: 01923 241004E-mail: david.dunham@medtronic.com
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.